Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Complete radiotherapy response in rectal cancer: A review of the evidence.

Couch DG, Hemingway DM.

World J Gastroenterol. 2016 Jan 14;22(2):467-70. doi: 10.3748/wjg.v22.i2.467. Review.

2.

Alternative clinical end points in rectal cancer--are we getting closer?

Glynne-Jones R, Mawdsley S, Pearce T, Buyse M.

Ann Oncol. 2006 Aug;17(8):1239-48.

PMID:
16873440
3.

High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.

Sun Myint A, Lee CD, Snee AJ, Perkins K, Jelley FE, Wong H.

Clin Oncol (R Coll Radiol). 2007 Nov;19(9):711-9. Epub 2007 Sep 19. Review.

PMID:
17884396
4.

Can positron emission tomography-computed tomography predict response in locally advanced rectal cancer patients treated with induction folinic acid and 5-florouracil?

Gunduz S, Coskun HS, Arslan D, Goksu SS, Tatli AM, Uysal M, Ozdogan M, Savas B.

Indian J Cancer. 2014 Apr-Jun;51(2):138-41. doi: 10.4103/0019-509X.138234.

5.
6.

Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.

Lin JZ, Zeng ZF, Wu XJ, Wan DS, Chen G, Li LR, Lu ZH, Ding PR, Pan ZZ.

J Int Med Res. 2010 Mar-Apr;38(2):645-54.

PMID:
20515578
7.

The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Tang JH, An X, Lin X, Gao YH, Liu GC, Kong LH, Pan ZZ, Ding PR.

Oncotarget. 2015 Oct 20;6(32):33919-25. doi: 10.18632/oncotarget.5287.

8.

Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.

Kim IJ, Lim SB, Kang HC, Chang HJ, Ahn SA, Park HW, Jang SG, Park JH, Kim DY, Jung KH, Choi HS, Jeong SY, Sohn DK, Kim DW, Park JG.

Dis Colon Rectum. 2007 Sep;50(9):1342-53.

PMID:
17665260
9.

Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer.

O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM.

Lancet Oncol. 2007 Jul;8(7):625-33. Review.

PMID:
17613424
10.

Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.

Nahas SC, Rizkallah Nahas CS, Sparapan Marques CF, Ribeiro U Jr, Cotti GC, Imperiale AR, Capareli FC, Chih Chen AT, Hoff PM, Cecconello I.

Dis Colon Rectum. 2016 Apr;59(4):255-63. doi: 10.1097/DCR.0000000000000558.

PMID:
26953983
11.

Management of complete response after chemoradiation in rectal cancer.

Weiser MR, Beets-Tan R, Beets G.

Surg Oncol Clin N Am. 2014 Jan;23(1):113-25. doi: 10.1016/j.soc.2013.09.012. Epub 2013 Oct 30. Review.

PMID:
24267169
12.

Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

Bampo C, Alessi A, Fantini S, Bertarelli G, de Braud F, Bombardieri E, Valvo F, Crippa F, Di Bartolomeo M, Mariani L, Milione M, Biondani P, Avuzzi B, Chiruzzi C, Pietrantonio F.

Oncology. 2013;84(4):191-9. doi: 10.1159/000345601. Epub 2013 Jan 15.

PMID:
23328390
13.

Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.

Engels B, Tournel K, Everaert H, Hoorens A, Sermeus A, Christian N, Storme G, Verellen D, De Ridder M.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):142-8. doi: 10.1016/j.ijrobp.2011.05.068. Epub 2011 Oct 17.

PMID:
22014952
14.

Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.

Habr-Gama A, Lynn PB, Jorge JM, São Julião GP, Proscurshim I, Gama-Rodrigues J, Fernandez LM, Perez RO.

Dis Colon Rectum. 2016 Apr;59(4):264-9. doi: 10.1097/DCR.0000000000000543.

PMID:
26953984
15.

Can we predict complete or major response after chemoradiotherapy for rectal cancer by noninvasive methods? Results of a prospective study on 61 patients.

Moszkowicz D, Peschaud F, El Hajjam M, Julié C, Beauchet A, Penna C, Nordlinger B, Benoist S.

Am Surg. 2014 Nov;80(11):1136-45.

PMID:
25347506
16.

Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum.

Wang ML, Heriot A, Leong T, Ngan SY.

Colorectal Dis. 2011 Mar;13(3):296-301. doi: 10.1111/j.1463-1318.2009.02154.x.

PMID:
20002695
17.

Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.

Folkvord S, Flatmark K, Dueland S, de Wijn R, Grøholt KK, Hole KH, Nesland JM, Ruijtenbeek R, Boender PJ, Johansen M, Giercksky KE, Ree AH.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):555-62. doi: 10.1016/j.ijrobp.2010.04.036. Epub 2010 Aug 2.

PMID:
20675069
18.

The Emerging Non-operative Management of Non-metastatic Rectal Cancer: A Population Analysis.

Abrams MJ, Koffer PP, Leonard KL.

Anticancer Res. 2016 Apr;36(4):1699-702.

PMID:
27069148
19.

CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.

Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A.

Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.

PMID:
23739192
20.

FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.

Ruby JA, Leibold T, Akhurst TJ, Shia J, Saltz LB, Mazumdar M, Riedel ER, Larson SM, Guillem JG.

Dis Colon Rectum. 2012 Apr;55(4):378-86. doi: 10.1097/DCR.0b013e318244a666.

PMID:
22426260

Supplemental Content

Support Center